259 related articles for article (PubMed ID: 34041484)
1. Fragment-based drug discovery: opportunities for organic synthesis.
St Denis JD; Hall RJ; Murray CW; Heightman TD; Rees DC
RSC Med Chem; 2020 Dec; 12(3):321-329. PubMed ID: 34041484
[TBL] [Abstract][Full Text] [Related]
2. Escape from planarity in fragment-based drug discovery: A synthetic strategy analysis of synthetic 3D fragment libraries.
Klein HF; Hamilton DJ; de Esch IJP; Wijtmans M; O'Brien P
Drug Discov Today; 2022 Sep; 27(9):2484-2496. PubMed ID: 35636722
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.
Coutard B; Decroly E; Li C; Sharff A; Lescar J; Bricogne G; Barral K
Antiviral Res; 2014 Jun; 106():61-70. PubMed ID: 24704437
[TBL] [Abstract][Full Text] [Related]
4. Recent Applications of Diversity-Oriented Synthesis Toward Novel, 3-Dimensional Fragment Collections.
Kidd SL; Osberger TJ; Mateu N; Sore HF; Spring DR
Front Chem; 2018; 6():460. PubMed ID: 30386766
[TBL] [Abstract][Full Text] [Related]
5. Fragment informatics and computational fragment-based drug design: an overview and update.
Sheng C; Zhang W
Med Res Rev; 2013 May; 33(3):554-98. PubMed ID: 22430881
[TBL] [Abstract][Full Text] [Related]
6. Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece.
Chan BWGL; Lynch NB; Tran W; Joyce JM; Savage GP; Meutermans W; Montgomery AP; Kassiou M
Front Chem; 2024; 12():1379518. PubMed ID: 38698940
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on Fragment-based Drug Discovery: A Strategy Applicable to Diverse Targets.
Li Q; Kang C
Curr Top Med Chem; 2021; 21(13):1099-1112. PubMed ID: 34348623
[TBL] [Abstract][Full Text] [Related]
8. Enabling synthesis in fragment-based drug discovery (FBDD): microscale high-throughput optimisation of the medicinal chemist's toolbox reactions.
Townley C; Branduardi D; Chessari G; Cons BD; Griffiths-Jones C; Hall RJ; Johnson CN; Ochi Y; Whibley S; Grainger R
RSC Med Chem; 2023 Dec; 14(12):2699-2713. PubMed ID: 38107176
[TBL] [Abstract][Full Text] [Related]
9. In silico fragment-based drug design.
Konteatis ZD
Expert Opin Drug Discov; 2010 Nov; 5(11):1047-65. PubMed ID: 22827744
[TBL] [Abstract][Full Text] [Related]
10. Fragment-based drug discovery-the importance of high-quality molecule libraries.
Bon M; Bilsland A; Bower J; McAulay K
Mol Oncol; 2022 Nov; 16(21):3761-3777. PubMed ID: 35749608
[TBL] [Abstract][Full Text] [Related]
11. Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunities.
Huang B; Kang D; Zhan P; Liu X
Expert Opin Drug Discov; 2015 Dec; 10(12):1271-81. PubMed ID: 26372893
[TBL] [Abstract][Full Text] [Related]
12. C-H functionalisation tolerant to polar groups could transform fragment-based drug discovery (FBDD).
Chessari G; Grainger R; Holvey RS; Ludlow RF; Mortenson PN; Rees DC
Chem Sci; 2021 Sep; 12(36):11976-11985. PubMed ID: 34667563
[TBL] [Abstract][Full Text] [Related]
13. Identification and structural characterization of small molecule fragments targeting Zika virus NS2B-NS3 protease.
Quek JP; Liu S; Zhang Z; Li Y; Ng EY; Loh YR; Hung AW; Luo D; Kang C
Antiviral Res; 2020 Mar; 175():104707. PubMed ID: 31953156
[TBL] [Abstract][Full Text] [Related]
14. Novel approach of fragment-based lead discovery applied to renin inhibitors.
Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
[TBL] [Abstract][Full Text] [Related]
15. Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery.
Morrison CN; Prosser KE; Stokes RW; Cordes A; Metzler-Nolte N; Cohen SM
Chem Sci; 2019 Dec; 11(5):1216-1225. PubMed ID: 34123246
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of dihydroisoquinolones for fragment-based drug discovery (FBDD).
Palmer N; Peakman TM; Norton D; Rees DC
Org Biomol Chem; 2016 Feb; 14(5):1599-610. PubMed ID: 26741115
[TBL] [Abstract][Full Text] [Related]
17. In Silico Structure-Based Approach for Group Efficiency Estimation in Fragment-Based Drug Design Using Evaluation of Fragment Contributions.
Shulga DA; Ivanov NN; Palyulin VA
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335347
[TBL] [Abstract][Full Text] [Related]
18. Recent Development in Small Molecules for SARS-CoV-2 and the Opportunity for Fragment-Based Drug Discovery.
Mahato S
Med Chem; 2022; 18(8):847-858. PubMed ID: 35156586
[TBL] [Abstract][Full Text] [Related]
19. Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges.
Togre NS; Vargas AM; Bhargavi G; Mallakuntla MK; Tiwari S
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142582
[TBL] [Abstract][Full Text] [Related]
20. Experiences in fragment-based drug discovery.
Murray CW; Verdonk ML; Rees DC
Trends Pharmacol Sci; 2012 May; 33(5):224-32. PubMed ID: 22459076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
